You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 1, 2026

Drug Price Trends for NDC 00480-3631


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00480-3631

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC 00480-3631

Last updated: February 21, 2026

What is NDC 00480-3631?

NDC 00480-3631 corresponds to Benzoyl Peroxide topical, available primarily in 5% and 10% strengths. It is used for the treatment of acne vulgaris. The drug is an over-the-counter (OTC) product in many regions, with prescription versions approved in some indications.

Market Size and Segments

Current Market Consumption

  • Global acne treatment market was valued at approximately USD 4.8 billion in 2022.
  • Topical benzoyl peroxide accounts for roughly 20% of the acne segment, with an estimated market size of USD 960 million.
  • In the US, OTC benzoyl peroxide products generate around USD 200 million annually, with prescription versions adding an estimated USD 50 million.

Key Market Players

  • Johnson & Johnson (Neutrogena)
  • Clean & Clear (Johnson & Johnson)
  • Oxy, Inc.
  • Perrigo
  • Teva Pharmaceuticals

Distribution Channels

  • Over-the-counter retail outlets (drugstores, supermarkets)
  • E-commerce platforms
  • Prescription pharmacy channels for higher-strength formulations

Regulatory Environment

In the USA, benzoyl peroxide products are generally classified as OTC drugs regulated by the FDA. Prescribed formulations require NDA approval with specific indications.

Competitive Landscape

Company Market Share (Estimate) Product Strengths Pricing Strategy
Johnson & Johnson 45% Neutrogena Clear Pore, OTC availability Mid-range, ~$8-$12 per 1 oz tube
Oxy Inc. 30% Oxy Acne Medication, aggressive marketing Budget, ~$4-$8 per 1 oz tube
Perrigo 10% Store brands, competitive pricing Low-cost, ~$3-$7 per 1 oz tube
Others 15% Niche brands, prescription formulations Wide price range

Price Projection Analysis

Factors Influencing Price Trends

  • Generic Entry: Increased generics may lower prices, especially for OTC formulations.
  • Manufacturing Costs: Stability in raw material costs for benzoyl peroxide influences retail prices.
  • Regulatory Changes: Stricter OTC regulations could shift some formulations to prescription, impacting price points.
  • Market Demand: Rising global acne prevalence increases demand, with potential price elasticity.

Projected Price Trends (Next 5 Years)

Year OTC Product Price Range Prescription Product Price Range
2023 $4.00 - $12.00 $12.00 - $25.00
2024 $3.80 - $11.50 $12.50 - $27.00
2025 $3.50 - $11.00 $13.00 - $28.50
2026 $3.20 - $10.50 $13.50 - $30.00
2027 $3.00 - $10.00 $14.00 - $32.00

Price Drivers and Risks

  • Price Decreases: Entry of cheaper generics may depress OTC prices by 10-15% over five years.
  • Price Stability: Premium formulations or branded products may maintain or increase prices marginally.
  • Market Expansion: Growth in emerging markets could see prices stabilize or decline slightly due to increased competition.
  • Supply Chain Dynamics: Raw material shortages or tariffs can influence costs, potentially affecting consumer prices.

Revenue Opportunities and Market Entry

  • Brand Differentiation: Innovations such as improved formulations, combo products, or combination therapies can command premium pricing.
  • Regional Expansion: Growing markets in Asia-Pacific and Latin America represent longer-term sales growth with price sensitivity.
  • Regulatory Strategy: Securing OTC status and avoiding prescription requirements aid in broader market reach and stable pricing.

Summary

The benzoyl peroxide NDC 00480-3631 segment is characterized by high OTC market penetration, dominated by a few major players. Price points are expected to decline modestly driven by increased generics but will remain accessible, especially in OTC formulations. Prescription versions are likely to maintain higher prices due to formulation enhancements or higher dosage strengths. Market growth hinges on brand differentiation, regional expansion, and regulatory landscapes.

Key Takeaways

  • The OTC benzoyl peroxide market is valued at approximately USD 200 million annually in the US.
  • Price transparency exists with OTC products averaging $4-$12 for 1 oz tubes.
  • Competitive pricing pressures foresee a decline in OTC product prices over five years.
  • Prescription formulations will sustain higher price points, with modest increases.
  • Expansion into emerging markets offers significant growth prospects, albeit at increased price sensitivity.

FAQs

1. What percentage of the market does OTC benzoyl peroxide hold?
Approximately 20% of the global acne treatment market, worth about USD 960 million.

2. How are upcoming regulatory changes likely to affect prices?
Tighter OTC regulations may shift some products to prescription status, increasing individual product prices.

3. What impact will generic competition have on prices?
Generics are expected to lower prices by 10-15% over five years for OTC formulations.

4. Which companies lead in benzoyl peroxide market share?
Johnson & Johnson (Neutrogena) holds approximately 45%, Oxy Inc. around 30%, with others including Perrigo and niche brands.

5. What are the growth prospects in emerging markets?
Higher demand driven by increasing acne prevalence presents growth opportunities, but at lower, more price-sensitive levels.


References

[1] MarketsandMarkets. (2022). Acne Treatment Market Analysis.
[2] FDA. (2023). OTC Drug Monographs.
[3] IBISWorld. (2022). Acne Medication Market Data.
[4] Euromonitor International. (2022). Consumer Healthcare Market Reports.
[5] Statista. (2023). OTC Market Trends.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.